# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-033768
Filing Date
2018-06-11
Accepted
2018-06-11 17:11:36
Documents
4
Period of Report
2018-07-12
Effectiveness Date
2018-06-11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tv496298_def14a.htm | DEF 14A | 154759
2 | GRAPHIC | image_003.jpg | GRAPHIC | 2938
3 | GRAPHIC | image_001.jpg | GRAPHIC | 369744
4 | GRAPHIC | image_002.jpg | GRAPHIC | 204490
| Complete submission text file | 0001144204-18-033768.txt |  | 951217

Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36598 | Film No.: 18892746
SIC: 2834 Pharmaceutical Preparations